Search results
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
Zacks via Yahoo Finance· 16 hours agoThis is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first...
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 14 hours agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 - Pfizer (NYSE:PFE)
Benzinga· 20 hours agoPfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5...
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
Motley Fool via Yahoo Finance· 3 days agoPfizer stock lost nearly half its value over the past couple of years, but some of the world's most...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 3 days agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
3 Biotech Stocks to Buy on the Dip: May 2024
InvestorPlace· 14 hours agoDespite their exciting growth potential and undeniable rewards, investors have been selling these stocks, causing a slight dip in price. Pfizer (NYSE:PFE ...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 7 days agoBecause of this, empirical studies indicate a strong correlation between trends in earnings estimate...
Pfizer (PFE) Recently Broke Out Above the 200-Day Moving Average
Zacks via Yahoo Finance· 18 hours agoFrom a technical perspective, Pfizer (PFE) is looking like an interesting pick, as it just reached a...
Is Pfizer Finally Seeing Light at the End of the Tunnel?
TheStreet.com· 16 hours agoPharmaceutical giant Pfizer (PFE) has been a weak performer in the stock market. The shares are...
Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)
Benzinga· 4 days agoRSI indicators hint that the underlying stock may be approaching overbought. Next earnings are expected to be released in 71 days. What The Experts Say On Pfizer& ...